The role of quercetin, flavonols and flavones in modulating inflammatory cell function

Inflammation and Allergy - Drug Targets

Volumn 9, Issue 4, 2010, Pages 263-285

  Chirumbolo, Salvatore ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Aryl hydrocarbon receptors; Basophils; Biphasic modulation; Flavonoids; Inflammation; Quercetin

Indexed keywords

3 HYDROXYFLAVONE; AGLYCONE; APIGENIN; AROMATIC HYDROCARBON RECEPTOR; BAICALEIN; BETA CAROTENE; CHRYSIN; CYTOKINE; DIOSMETIN; FISETIN; GALANGIN; GOSSYPETIN; KAEMPFEROL; LUTEOLIN; MORIN; MYRICETIN; QUERCETIN; RHAMNETIN; SCUTELLAREIN; WOGONIN;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BASOPHIL; CELL FUNCTION; CELL MEMBRANE; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; ENZYME ACTIVITY; HELICOBACTER INFECTION; HERPES VIRUS INFECTION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INFLAMMATORY CELL; LEISHMANIASIS; LIVER FIBROSIS; MAST CELL; NONHUMAN; PARASITOSIS; SCLEROSIS; SIGNAL TRANSDUCTION; VIRUS INFECTION;

EID: 79751471302     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152810793358741     Document Type: Article

References (305)

1. Hollman, P.C.; Katan, M.B. Health effects and bioavailability of dietary flavonols. Free Radic. Res., 1999, 31 (Suppl), S75-S80.
2. Hollman, P.C.; Katan, M.B. Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol., 1999, 37, 937-942.
3. Yang, R.Y.; Lin, S.; Kuo, G. Content and distribution of flavonoids among 91 edible plant species. Asia Pac. J. Clin. Nutr., 2008, 17(Suppl 1), 275-279.
4. Ross, J.A.; Kasum, C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 2002, 22, 19-34.
5. Lu, S.; Zhou, Y.; Li, L.; Chiang, V.L Distinct roles of cinnamate-4- hydrolase genes in Populus. Plant Cell Physiol., 2006, 47, 905-914.
6. Winkel-Shirley B. Flavonoids biosynthesis. a colourful model for genetics, biochemistry, cell biology and biotechnology. Plant Physiol., 2001, 126, 485-493.
7. Olsen, K.M.; Slimestad, R.; Lea, U.S.; Brede, C.; Lovdal, T.; Ruoff, P.; Verheul, M.; Lillo, C. Temperature and nitrogen effects on regulators and products of the flavonoid pathway: experimental and kinetic model studies. Plant Cell Environ., 2009, 32, 286-299.
8. Albert, A.; Sareedenchai, V.; Heller, W.; Seidlitz, H.K.; Zidorn, C. Temperature is the key to altitudinal variation of phenolics in Arnica montana L. cv. ARBO. Oecologia., 2009, 160, 1-8.
9. Cazarolli, L.H.; Zanatta, L.; Alberton, E.H.; Figueiredo, M.S.; Folador, P.; Damazio, R.G.; Pizzolatti, M.G.; Silva, F.R. Flavonoids: prospective drug candidates. Mini Rev. Med. Chem., 2008, 8, 1429-1440.
10. Yang, X.H.; Liu, Y.Y.; Liu, L.J.; Zhou, X.P.; Toshio, S. A new flavonoid glycoside from Allium cepa L. var agrogatum Don. Yao. Xue. Xue. Bao., 2000, 35, 752-755.
11. Rodriguez, G.B.; Rodriguez, E.M.; Diaz, R.C. Flavonoids in onion cultivars (Allium cepa L.). J. Food Sci., 2008, 73, C599-C605.
12. Crozier, A.; Jaganath, I.B.; Clifford, M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep., 2009, 26, 1001-1043.
13. Veitch, N.C.; Grayer, R.J. Flavonoids and their glycosides, including anthocyanins. Nat. Prod. Rep., 2008, 25, 555-611.
14. Gutzeit, H.O.; Tokalov, S.V.; Ludwig-Muller, J.; Rusak, G. Monitoring flavonoid metabolism in human cells by exploiting fluorescence elicited upon quercetin/protein interactions. Croat. Chem. Acta., 2005, 78, 337-342.
15. Williamson, G.; Day, J.; Plumb, G.W.; Couteau, G. Human metabolic pathways of dietary flavonoids and cinnamates. Biochem. Soc. Trans., 2000, 28, 16-22.
16. Day, A.J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M.R.; Williamson, G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic. Res., 2001, 35, 941-952.
17. Loke, W.M.; Jenner, A.M.; Proudfoot, J.M.; McKinley, A.J.; Hodgson, J.M.; Halliwell, B.; Croft, K.D. A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J. Nutr., 2009, 139, 2309-2314.
18. Berg, P.A.; Daniel, P.T. Effects of flavonoid compounds on the immune response. Prog. Clin. Biol. Res., 1988, 280, 157-171.
19. Serafini, M.; Peluso, I.; Raguzzini, A. Flavonoids as antiinflammatory agents. Proc. Nutr. Soc., 2010, 69, 273-278.
20. Garcia-Lafuente, A.; Guillamon, E.; Villares, A.; Rostagno, M.A.; Martinez, J.A. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res., 2009, 58, 537-552.
21. Middleton, E. Jr. Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol., 1998, 439, 175-182.
22. Guardia, T.; Rotelli, A.E.; Juarez, A.O.; Pelzer, L.E. Antiinflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco., 2001, 56, 683-687.
23. Borrelli, F.; Maffia, P.; Pinto, L.; Ianaro, A.; Russo, A.; Capasso, F.; Ialenti, A. Phytochemical compounds involved in the antiinflammatory effect of propolis extract. Fitoterapia., 2002, 73, S53-S63.
24. Rotelli, A.E.; Guardia, T.; Juarez, A.O.; de la Rocha, N.E.; Pelzer, L.E. Comparative study of flavonoids in experimental models of inflammation. Pharmacol. Res., 2003, 48, 601-606.
25. Chiang, L.C.; Ng, L.T.; Chiang, W.; Chang, M.Y.; Lin, C.C. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med., 2003, 69, 600-604.
26. Wu, C.H.; Wu, C.F.; Huang, H.W.; Jao, Y.C.; Yen, G.C. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Mol. Nutr. Food Res., 2009, 53, 984-995.
27. Du Toit, K.; Buthelezi, S.; Bodenstein, J. Anti-inflammatory and antibacterial profiles of selected compounds found in South African propolis. S. Afr. J. Sci., 2009, 105, 470-472.
28. el-Gammal, A.A.; Mansour, R.M. Antimicrobial activities of some flavonoid compounds. Zentralbl. Mikrobiol., 1986, 141, 561-565.
29. Song, Y.; Manson, J.E.; Buring, J.E.; Sesso, H.D.; Liu, S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J. Am. Coll. Nutr., 2005, 24, 376-384.
30. Tormakangas, L.; Vuorela, P.; Saario, E.; Leinonen, M.; Saikku, P.; Vuorela, H. In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model. Biochem. Pharmacol., 2005, 70, 1222-1230.
31. Kumazawa, Y.; Kawaguchi, K.; Takimoto, H. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr. Pharm. Des., 2006, 12, 4271-4279.
32. Hamalainen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NFkappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm., 2007, 2007, 45673
33. Gonzalez-Segovia, R.; Quintanar, J.L.; Salinas, E.; Ceballos-Salazar, R.; Viles-Jimenez, F.; Torres-Lopez, J. Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig. J. Gastroenterol., 2008, 43, 441-447.
34. Loke, W.M.; Proudfoot, J.M.; Hodgson, J.M.; McKinley, A.J.; Hime, N.; Magat, M.; Stocker, R.; Croft, K.D. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 749-757.
35. Heinz, S.A.; Henson, D.A.; Nieman, D.C.; Austin, M.D.; Jin, F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br. J. Nutr., 2010, 1-9.
36. Heinz, S.A.; Henson, D.A.; Austin, M.D.; Jin, F.; Nieman, D.C. Quercetin supplementation and upper respiratory tract infection: a randomized community clinical trial. Pharmacol. Res., 2010, 62, 237-242.
37. Comalada, M.; Camuesco, D.; Sierra, S.; Ballester, I.; Xaus, J.; Galvez, J.; Zarzuelo, A. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur. J. Immunol., 2005, 35, 584-592.
38. Xu, H.X.; Wan, M.; Dong, H.; But, P.P.; Foo, L.Y. Inhibitory activity of flavonoids and tannins against HIV-1 protease. Biol. Pharm. Bull., 2000, 23, 1072-1076.
39. Xu, H.X.; Lee, S.F. Activity of plant flavonoids against antibioticresistant bacteria. Phytother. Res., 2001, 15, 39-43.
40. Jung, M.; Triebel, S.; Anke, T.; Richling, E.; Erkel, G. Influence of apple polyphenols on inflammatory gene expression. Mol. Nutr. Food Res., 2009, 53, 1263-1280.
41. Wleklik, M.; Luczak, M.; Panasiak, W.; Kobus, M.; Lammer-Zarawska, E. Structural basis for antiviral activity of flavonoidsnaturally occurring compounds. Acta. Virol., 1988, 32, 522-525.
42. Wang, L.; Tu, Y.C.; Lian, T.W.; Hung, J.T.; Yen, J.H.; Wu, M.J. Distinctive antioxidant and antiinflammatory effects of flavonols. J. Agric. Food Chem., 2006, 54, 9798-9804.
43. Tsuchiya, H. Structure-dependent membrane interaction of flavonoids associated with their bioactivity. Food Chem., 2010, 120, 1089-1096.
44. Cheong, H.; Ryu, S.Y.; Oak, M.H.; Cheon, S.H.; Yoo, G.S.; Kim, K.M. Studies of structure activity relationship of flavonoids for the anti-allergic actions. Arch. Pharm. Res., 1998, 21, 478-480.
45. Li, J.J. Algar-Flynn-Oyamada reaction. In Name Reactions, Springer: Berlin Heidelberg, 2009, pp. 6-7.
46. Daniel, M. Medicinal plants-chemistry and properties. Science, Publishers: Enfield New Hampshire, USA, 2006, p. 78.
47. Si, D.; Wang, Y.; Zhou, Y.H.; Guo, Y.; Wang, J.; Zhou, H.; Li, Z.S.; Fawcett, J.P. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab. Dispos., 2009, 37, 629-634.
48. Bakay, M.; Mucsi, I.; Beladi, I.; Gabor, M. Effect of flavonoids and related substances. II. Antiviral effect of quercetin, dihydroquercetin and dihydrofisetin. Acta. Microbiol. Acad. Sci. Hung., 1968, 15, 223-227.
49. Akaishi, T.; Morimoto, T.; Shibao, M.; Watanabe, S.; Sakai-Kato, K.; Utsunomiya-Tate, N.; Abe, K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci. Lett., 2008, 444, 280-285.
50. Hosny, M.; Dhar, K.; Rosazza, J.P. Hydroxylations and methylations of quercetin, fisetin, and catechin by Streptomyces griseus. J. Nat. Prod., 2001, 64, 462-465.
51. De Santi, C.; Pietrabissa, A.; Mosca, F.; Pacifici, G.M. Methylation of quercetin and fisetin, flavonoids widely distributed in edible vegetables, fruits and wine, by human liver. Int. J. Clin. Pharmacol. Ther., 2002, 40, 207-212.
52. Huang, R.Y.; Yu, Y.L.; Cheng, W.C.; OuYang, C.N.; Fu, E.; Chu, C.L. Immunosuppressive effect of quercetin on dendritic cell activation and function. J. Immunol., 2010, 184, 6815-6821.
53. Butenko, I.G.; Gladtchenko, S.V.; Galushko, S.V. Antiinflammatory properties and inhibition of leukotriene C4 biosynthesis in-vitro by flavonoid baicalein from Scutellaria baicalensis Georgy roots. Agents Actions, 1993, 39, C49-C51.
54. Kimura, Y.; Okuda, H.; Hayashi, K.Y.; Matsushita, N. Effects of baicalein isolated from roots of Scutellaria baicalensis Georgi on interleukin 1 beta- and tumour necrosis factor alpha-induced tissuetype plasminogen activator and plasminogen activator inhibitor-1 production in cultured human umbilical vein endothelial cells. Phytother. Res., 1997, 11, 363-367.
55. Lim, H.; Kim, H.P. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids. Planta Med., 2007, 73, 1267-1274.
56. Kakegawa, H.; Matsumoto, H.; Satoh, T. Inhibitory effects of some natural-products on the activation of hyaluronidase and their antiallergic actions. Chem. Pharm. Bull., 1992, 40, 1439-1442.
57. Tanno, Y.; Shindoh, Y.; Takishima, T. Modulation of human basophil growth in vitro by xiao-qing-long-tang (syo-seiryu-to), chai-pu-tang (saiboku-to), qing-fei-tang (seihai-to), baicalein and ketotifen. Am. J. Chin. Med., 1989, 17, 45-50.
58. Kawasaki, M.; Toyoda, M.; Teshima, R.; Sawada, J.; Hayashi, T.; Arisawa, M.; Shimizu, M.; Morita, N.; Inoue, S.; Saito, Y. In-vitro antiallergic activity of flavonoids in histamine-release assay using rat basophilic leukemia (RBL-2H3) cells. Shokuhin. Eiseigaku. Zasshi., 1994, 35, 497-503.
59. Amellal, M.; Bronner, C.; Briancon, F.; Haag, M.; Anton, R.; Landry, Y. Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med., 1985, 51, 16-20.
60. Wakabayashi, I.; Yasui, K. Wogonin inhibits inducible prostaglandin E-2 production in macrophages. Eur. J. Pharmacol., 2000, 406, 477-481.
61. Wakabayashi, I. Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol. Toxicol., 1999, 84, 288-291.
62. Pagonis, C.; Tauber, A.I.; Pavlotsky, N.; Simons, E.R. Flavonoid impairment of neutrophil response. Biochem. Pharmacol., 1986, 35, 237-245.
63. Busse, W.W.; Kopp, D.E.; Middleton, E. Jr. Flavonoid modulation of human neutrophil function. J. Allergy Clin. Immunol., 1984, 73, 801-809.
64. Della, L.R.; Ragazzi, E.; Tubaro, A.; Fassina, G.; Vertua, R. Antiinflammatory activity of benzopyrones that are inhibitors of cycloand lipo-oxygenase. Pharmacol. Res. Commun., 1988, 20 (Suppl 5), 91-94.
65. Medeiros, K.C.; Faustino, L.; Borduchi, E.; Nascimento, R.J.; Silva, T.M.; Gomes, E.; Piuvezam, M.R.; Russo, M. Preventive and curative glycoside kaempferol treatments attenuate the TH2-driven allergic airway disease. Int. Immunopharmacol., 2009, 9, 1540-1548.
66. Debiaggi, M.; Tateo, F.; Pagani, L.; Luini, M.; Romero, E. Effects of propolis flavonoids on virus infectivity and replication. Microbiologica, 1990, 13, 207-213.
67. Choi, H.J.; Kim, J.H.; Lee, C.H.; Ahn, Y.J.; Song, J.H.; Baek, S.H.; Kwon, D.H. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res., 2009, 81, 77-81.
68. Zhang, T.; Chen, D. Anticomplementary principles of a Chinese multiherb remedy for the treatment and prevention of SARS. J. Ethnopharmacol., 2008, 117, 351-361.
69. Min, B.S.; Tomiyama, M.; Ma, C.M.; Nakamura, N.; Hattori, M. Kaempferol acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency virus-1 reverse transcriptase. Chem. Pharm. Bull. (Tokyo), 2001, 49, 546-550.
70. Robin, V.; Irurzun, A.; Amoros, M.; Boustie, J.; Carrasco, L. Antipoliovirus flavonoids from Psiadia dentata. Antivir. Chem. Chemother., 2001, 12, 283-291.
71. Mitrocotsa, D.; Mitaku, S.; Axarlis, S.; Harvala, C.; Malamas, M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med., 2000, 66, 377-379.
72. Wei, B.L.; Lu, C.M.; Tsao, L.T.; Wang, J.P.; Lin, C.N. In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rhamnus species. Planta Med., 2001, 67, 745-747.
73. Kataoka, M.; Hirata, K.; Kunikata, T.; Ushio, S.; Iwaki, K.; Ohashi, K.; Ikeda, M.; Kurimoto, M. Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J. Gastroenterol., 2001, 36, 5-9.
74. Alexandrakis, M.; Letourneau, R.; Kempuraj, D.; Kandere-Grzybowska, K.; Huang, M.; Christodoulou, S.; Boucher, W.; Seretakis, D.; Theoharides, T.C. Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1). Eur. J. Haematol., 2003, 71, 448-454.
75. Kupeli, E.; Yesilada, E. Flavonoids with anti-inflammatory and antinociceptive activity from Cistus laurifolius L. leaves through bioassay-guided procedures. J. Ethnopharmacol., 2007, 112, 524-530.
76. Jiang, H.; Hu, J.R.; Zhan, W.Q.; Liu, X. Screening for fractions of Oxytropis falcata Bunge with antibacterial activity. Nat. Prod. Res., 2009, 23, 953-959.
77. Marin, C.; Boutaleb-Charki, S.; Diaz, J.G.; Huertas, O.; Rosales, M.J.; Perez-Cordon, G.; Guitierrez-Sanchez, R.; Sanchez-Moreno, M. Antileishmaniasis activity of flavonoids from Consolida oliveriana. J. Nat. Prod., 2009, 72, 1069-1074.
78. Mittra, B.; Saha, A.; Chowdhury, A.R.; Pal, C.; Mandal, S.; Mukhopadhyay, S.; Bandyopadhyay, S.; Majumder, H.K. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol. Med., 2000, 6, 527-541.
79. Cimanga, R.K.; Kambu, K.; Tona, L.; Hermans, N.; Apers, S.; Totte, J.; Pieters, L.; Vlietinck, A.J. Cytotoxicity and in vitro susceptibility of Entamoeba histolytica to Morinda morindoides leaf extracts and its isolated constituents. J. Ethnopharmacol., 2006, 107, 83-90.
80. Tasdemir, D.; Kaiser, M.; Brun, R.; Yardley, V.; Schmidt, T.J.; Tosun, F.; Ruedi, P. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob. Agents Chemother., 2006, 50, 1352-1364.
81. Das, B.B.; Sen, N.; Roy, A.; Dasgupta, S.B.; Ganguly, A.; Mohanta, B.C.; Dinda, B.; Majumder, H.K. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I. Nucleic Acids Res., 2006, 34, 1121-1132.
82. Shim, S.Y.; Seo, Y.K.; Park, J.R. Down-regulation of FcepsilonRI expression by Houttuynia cordata Thunb extract in human basophilic KU812F cells. J. Med. Food, 2009, 12, 383-388.
83. Shim, S.Y.; Choi, J.S.; Byun, D.S. Kaempferol isolated from Nelumbo nucifera stamens negatively regulates FcepsilonRI expression in human basophilic KU812F cells. J. Microbiol. Biotechnol., 2009, 19, 155-160.
84. Lee, E.J.; Ji, G.E.; Sung, M.K. Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells. Inflamm. Res., 2010, (in press).
85. Mahat, M.Y.; Kulkarni, N.M.; Vishwakarma, S.L.; Khan, F.R.; Thippeswamy, B.S.; Hebballi, V.; Adhyapak, A.A.; Benade, V.S.; Ashfaque, S.M.; Tubachi, S.; Patil, B.M. Modulation of the cyclooxygenase pathway via inhibition of nitric oxide production contributes to the anti-inflammatory activity of kaempferol. Eur. J. Pharmacol., 2010.
86. Seelinger, G.; Merfort, I.; Schempp, C.M. Anti-oxidant, antiinflammatory and anti-allergic activities of luteolin. Planta Med., 2008, 74, 1667-1677.
87. Tordera, M.; Ferrandiz, M.L.; Alcaraz, M.J. Influence of antiinflammatory flavonoids on degranulation and arachidonic acid release in rat neutrophils. Z. Naturforsch. C., 1994, 49, 235-240.
88. Kang, O.H.; Choi, J.G.; Lee, J.H.; Kwon, D.Y. Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells. Molecules, 2010, 15, 385-398.
89. Kimata, M.; Inagaki, N.; Nagai, H. Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta Med., 2000, 66, 25-29.
90. Dirscherl, K.; Karlstetter, M.; Ebert, S.; Kraus, D.; Hlawatsch, J.; Walczak, Y.; Moehle, C.; Fuchshofer, R.; Langmann, T. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J. Neuroinflamm., 2010, 7, 3.
91. Theoharides, T.C. Luteolin as a therapeutic option for multiple sclerosis. J. Neuroinflamm., 2009, 6, 29.
92. Sternberg, Z.; Chadha, K.; Lieberman, A.; Drake, A.; Hojnacki, D.; Weinstock-Guttman, B.; Munschauer, F. Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta. J. Neuroinflamm., 2009, 6, 28.
93. Domitrovic, R.; Jakovac, H.; Tomac, J.; Sain, I. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol. Appl. Pharmacol., 2009, 241, 311-321.
94. Figueirinha, A.; Cruz, M.T.; Francisco, V.; Lopes, M.C.; Batista, M.T. Anti-inflammatory activity of Cymbopogon citratus leaf infusion in lipopolysaccharide-stimulated dendritic cells: contribution of the polyphenols. J. Med. Food, 2010, 13, 681-690.
95. Bronner, C. and Landry, Y. Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions, 1985, 16, 147-151.
96. Middleton E Jr; Fujiki, H.; Savliwala, M.; Drzewiecki, G. Tumor promoter-induced basophil histamine release: effect of selected flavonoids. Biochem. Pharmacol., 1987, 36, 2048-2052.
97. Hirano, T.; Arimitsu, J.; Higa, S.; Naka, T.; Ogata, A.; Shima, Y.; Fujimoto, M.; Yamadori, T.; Ohkawara, T.; Kuwabara, Y.; Kawai, M.; Kawase, I.; Tanaka, T. Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils. Int. Arch. Allergy Immunol., 2006, 140, 150-156.
98. Hirano, T.; Higa, S.; Arimitsu, J.; Naka, T.; Ogata, A.; Shima, Y.; Fujimoto, M.; Yamadori, T.; Ohkawara, T.; Kuwabara, Y.; Kawai, M.; Matsuda, H.; Yoshikawa, M.; Maezaki, N.; Tanaka, T.; Kawase, I.; Tanaka, T. Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem. Biophys. Res. Commun., 2006, 340, 1-7.
99. Papaliodis, D.; Boucher, W.; Kempuraj, D.; Theoharides, T.C. The flavonoid luteolin inhibits niacin-induced flush. Br. J. Pharmacol., 2008, 153, 1382-1387.
100. Jin, M.; Yang, J.H.; Lee, E.; Lu, Y.; Kwon, S.; Son, K.H.; Son, J.K.; Chang, H.W. Antiasthmatic activity of luteolin-7-O-glucoside from Ailanthus altissima through the downregulation of T helper 2 cytokine expression and inhibition of prostaglandin E2 production in an ovalbumin-induced asthma model. Biol. Pharm. Bull., 2009, 32, 1500-1503.
101. Leemans, J.; Cambier, C.; Chandler, T.; Billen, F.; Clercx, C.; Kirschvink, N.; Gustin, P. Prophylactic effects of omega-3 polyunsaturated fatty acids and luteolin on airway hyperresponsiveness and inflammation in cats with experimentallyinduced asthma. Vet. J., 2010, 184, 111-114.
102. Pieroni, A.; Heimler, D.; Pieters, L.; Van, P.B.; Vlietinck, A.J. In vitro anti-complementary activity of flavonoids from olive (Olea europaea L.) leaves. Pharmazie, 1996, 51, 765-768.
103. Kim, E.K.; Kwon, K.B.; Song, M.Y.; Han, M.J.; Lee, J.H.; Lee, Y.R.; Lee, J.H.; Ryu, D.G.; Park, B.H.; Park, J.W. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation. Pancreas, 2007, 35, e1-e9.
104. Ramesh, N.; Viswanathan, M.B.; Saraswathy, A.; Balakrishna, K.; Brindha, P.; Lakshmanaperumalsamy, P. Phytochemical and antimicrobial studies of Begonia malabarica. J. Ethnopharmacol., 2002, 79, 129-132.
105. Tereschuk, M.L.; Baigori, M.D.; De Figueroa, L.I.; Abdala, L.R. Flavonoids from Argentine Tagetes (Asteraceae) with antimicrobial activity. Methods Mol. Biol., 2004, 268, 317-330.
106. Ueda, H.; Yamazaki, C.; Yamazaki, M. A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-alpha production. Biosci. Biotechnol. Biochem., 2004, 68, 119-125.
107. Nsonde Ntandou, G.F.; Banzouzi, J.T.; Mbatchi, B.; Elion-Itou, R.D.; Etou-Ossibi, A.W.; Ramos, S.; oit-Vical, F.; Abena, A.A.; Ouamba, J.M. Analgesic and anti-inflammatory effects of Cassia siamea Lam. stem bark extracts. J. Ethnopharmacol., 2010, 127, 108-111.
108. Mastuda, H.; Morikawa, T.; Ueda, K.; Managi, H.; Yoshikawa, M. Structural requirements of flavonoids for inhibition of antigen- Induced degranulation, TNF-alpha and IL-4 production from RBL-2H3 cells. Bioorg. Med. Chem., 2002, 10, 3123-3128.
109. Casetti, F.; Jung, W.; Wolfle, U.; Reuter, J.; Neumann, K.; Gilb, B.; Wahling, A.; Wagner, S.; Merfort, I.; Schempp, C.M. Topical application of solubilized Reseda luteola extract reduces ultraviolet B-induced inflammation in vivo. J. Photochem. Photobiol. B., 2009, 96, 260-265.
110. Rotelli, A.E.; Aguilar, C.F.; Pelzer, L.E. Structural basis of the anti-inflammatory activity of quercetin: inhibition of the 5- Hydroxytryptamine Type 2 Receptor. Eur. Biophys. J., 2009, 38(7), 865-871
111. Harasstani, O.A.; Moin, S.; Tham, C.L.; Liew, C.Y.; Ismail, N.; Rajajendram, R.; Harith, H.H.; Zakaria, Z.A.; Mohamad, A.S.; Sulaiman, M.R.; Israf, D.A. Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells. Inflamm. Res., 2010, in press
112. Tong, Y.; Zhou, X.M.; Wang, S.J.; Yang, Y.; Cao, Y.L. Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Arch. Pharm. Res., 2009, 32, 527-533.
113. Wang, S.J.; Tong, Y.; Lu, S.; Yang, R.; Liao, X.; Xu, Y.F.; Li, X. Anti-inflammatory activity of myricetin isolated from myrica rubra Sieb. et Zucc. leaves. Planta Med., 2010, in press
114. Park, H.H.; Lee, S.; Son, H.Y.; Park, S.B.; Kim, M.S.; Choi, E.J.; Singh, T.S.; Ha, J.H.; Lee, M.G.; Kim, J.E.; Hyun, M.C.; Kwon, T.K.; Kim, Y.H.; Kim, S.H. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharm. Res., 2008, 31, 1303-1311.
115. Medeiros, K.C.; Figueiredo, C.A.; Figueredo, T.B.; Freire, K.R.; Santos, F.A.; Cantara-Neves, N.M.; Silva, T.M.; Piuvezam, M.R. Anti-allergic effect of bee pollen phenolic extract and myricetin in ovalbumin-sensitized mice. J. Ethnopharmacol., 2008, 119, 41-46.
116. Duthie, S.J.; Collins, A.R.; Duthie, G.G.; Dobson, V.L. Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes. Mutat. Res., 1997, 393, 223-231.
117. Kimata, M.; Shichijo, M.; Miura, T.; Serizawa, I.; Inagaki, N.; Nagai, H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy, 2000, 30, 501-508.
118. Limasset, B.; Ledoucen, C.; Dore, J.C.; Ojasoo, T.; Damon, M.; Depaulet, A.C. effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils - multivariateanalysis of structure-activity-relationships (Sar). Biochem. Pharmacol., 1993, 46, 1257-1271.
119. Tomasbarberan, F.A.; Ferreres, F.; Tomaslorente, F.; Ortiz, A. Flavonoids from apis-mellifera beeswax. Z. Naturforsch. C., 1993, 48, 68-72.
120. Siess, M.H.; Lebon, A.M.; CanivencLavier, M.C.; Amiot, M.J.; Sabatier, S.; Aubert, S.Y.; Suschetet, M. Flavonoids of honey and propolis: characterization and effects on hepatic drug-metabolizing enzymes and benzo[a]pyrene-DNA binding in rats. J. Agric. Food Chem., 1996, 44, 2297-2301.
121. Ferreres, F.; Andrade, P.; Tomasbarberan, F.A. Flavonoids from Portuguese Heather Honey. Zeitschrift fur Lebensmittel- Untersuchung Und-Forschung, 1994, 199, 32-37.
122. Soler, C.; Gil, M.; Garciaviguera, C.; Tomasbarberan, F.A. Flavonoid patterns of French honeys with different floral origin. Apidologie, 1995, 26, 53-60.
123. Mirzoeva, O.K. and Calder, P.C. The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leukot. Essent. Fatty Acids, 1996, 55, 441-449.
124. Ansorge, S.; Reinhold, D.; Lendeckel, U. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells. Z. Naturforsch. C., 2003, 58, 580-589.
125. Heo, M.Y.; Sohn, S.J.; Au, W.W. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat. Res., 2001, 488, 135-150.
126. Ji, X.D.; Melman, N.; Jacobson, K.A. Interactions of flavonoids and other phytochemicals with adenosine receptors. J. Med. Chem., 1996, 39, 781-788.
127. Livingston, M.; Heaney, L.G.; Ennis, M. Adenosine, inflammation and asthma--a review 566. Inflamm.Res., 2004, 53, 171-178.
128. Park, Y.K.; Koo, M.H.; Ikegaki, M.; Cury, J.A.; Rosalen, P.L. Effects of propolis on Streptococcus mutans, Actinomyces naeslundii and Staphylococcus aureus. Revista de Microbiol., 1998, 29, 143-148.
129. Afolayan, A.J.; Meyer, J.J.M. The antimicrobial activity of 3,5,7- trihydroxyflavone isolated from the shoots of Helichrysum aureonitens. J. Ethnopharmacol., 1997, 57, 177-181.
130. Cushnie, T.P.T.; Hamilton, V.E.S.; Lamb, A.J. Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports. Microbiol. Res., 2003, 158, 281-289.
131. Pepeljnjak, S.; Kosalec, I. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa. Fems. Microbiol. Lett., 2004, 240, 111-116.
132. Meyer, J.J.M.; Afolayan, A.J.; Taylor, M.B.; Erasmus, D. Antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens. J. Ethnopharmacol., 1997, 56, 165-169.
133. Ferrandiz, M.L.; Alcaraz, M.J. Antiinflammatory activity and inhibition of arachidonic-acid metabolism by flavonoids. Agents Actions, 1991, 32, 283-288.
134. Mounnissamy, V.M.; Gopal, V.; Gunasegaran, R.; Saraswathy, A. Antiinflammatory activity of gossypetin isolated from Hibiscus sabdariffa. Indian J. Heterocycl. Chem., 2002, 12, 85-86.
135. Geraets, L.; Moonen, H.J.J.; Brauers, K.; Wouters, E.F.M.; Bast, A.; Hageman, G.J. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J. Nutr., 2007, 137, 2190-2195.
136. Hirano, T.; Higa, S.; Arimitsu, J.; Naka, T.; Shima, Y.; Ohshima, S.; Fujimoto, M.; Yamadori, T.; Kawase, I.; Tanaka, T. Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. Int. Arch. Allergy Immunol., 2004, 134, 135-140.
137. Lee, S.; Kim, Y.J.; Kwon, S.; Lee, Y.; Choi, S.Y.; Park, J.; Kwon, H.J. Inhibitory effects of flavonoids on TNF-alpha-induced IL-8 gene expression in HEK 293 cells. BMB Rep., 2009, 42, 265-270.
138. Geraets, L.; Haegens, A.; Brauers, K.; Haydock, J.A.; Vernooy, J.H.; Wouters, E.F.; Bast, A.; Hageman, G.J. Inhibition of LPSinduced pulmonary inflammation by specific flavonoids. Biochem. Biophys. Res. Commun., 2009, 382, 598-603.
139. Lee, J.D.; Huh, J.E.; Jeon, G.; Yang, H.R.; Woo, H.S.; Choi, D.Y.; Park, D.S. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int. Immunopharmacol., 2009, 9, 268-276.
140. Higa, S.; Hirano, T.; Kotani, M.; Matsumoto, M.; Fujita, A.; Suemura, M.; Kawase, I.; Tanaka, T. Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J. Allergy Clin. Immunol., 2003, 111, 1299-1306.
141. Lyu, S.Y.; Park, W.B. Production of cytokine and NO by RAW 264.7 macrophages and PBMC in vitro incubation with flavonoids. Arch. Pharm. Res., 2005, 28, 573-581.
142. Xagorari, A.; Papapetropoulos, A.; Mauromatis, A.; Economou, M.; Fotsis, T.; Roussos, C. Luteolin inhibits an endotoxinstimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J. Pharmacol. Exp. Ther., 2001, 296, 181-187.
143. Hougee, S.; Sanders, A.; Faber, J.; Graus, Y.M.; van den Berg, W.B.; Garssen, J.; Smit, H.F.; Hoijer, M.A. Decreased proinflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem. Pharmacol., 2005, 69, 241-248.
144. Kempuraj, D.; Madhappan, B.; Christodoulou, S.; Boucher, W.; Cao, J.; Papadopoulou, N.; Cetrulo, C.L.; Theoharides, T.C. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol., 2005, 145, 934-944.
145. Nagai, K.; Takahashi, Y.; Mikami, I.; Fukusima, T.; Oike, H.; Kobori, M. The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes. Br. J. Pharmacol., 2009, 158, 907-919.
146. Chen, C.C.; Chow, M.P.; Huang, W.C.; Lin, Y.C.; Chang, Y.J. Flavonoids inhibit tumor necrosis factor-alpha-induced upregulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Mol. Pharmacol., 2004, 66, 683-693.
147. Comalada, M.; Ballester, I.; Bailon, E.; Sierra, S.; Xaus, J.; Galvez, J.; de Medina, F.S.; Zarzuelo, A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem. Pharmacol., 2006, 72, 1010-1021.
148. Takano-Ishikawa, Y.; Goto, M.; Yamaki, K. Inhibitory effects of several flavonoids on E-selectin expression on human umbilical vein endothelial cells stimulated by tumor necrosis factor-alpha. Phytother. Res., 2003, 17, 1224-1227.
149. Sharma, V.; Mishra, M.; Ghosh, S.; Tewari, R.; Basu, A.; Seth, P.; Sen, E. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res. Bull., 2007, 73, 55-63.
150. Yeh, S.L.; Wang, H.M.; Chen, P.Y.; Wu, T.C. Interactions of betacarotene and flavonoids on the secretion of pro-inflammatory mediators in an in vitro system. Chem. Biol. Interact., 2009, 179, 386-393.
151. Tang, D.; Kang, R.; Xiao, W.; Zhang, H.; Lotze, M.T.; Wang, H.; Xiao, X. Quercetin prevents lipopolysaccharide-induced hmgb1 release and proinflammatory function. Am. J. Respir. Cell Mol. Biol., 2009.
152. Williams, R.J.; Spencer, J.P.; Rice-Evans, C. Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med., 2004, 36, 838-849.
153. Kaneko, M.; Takimoto, H.; Sugiyama, T.; Seki, Y.; Kawaguchi, K.; Kumazawa, Y. Suppressive effects of the flavonoids quercetin and luteolin on the accumulation of lipid rafts after signal transduction via receptors. Immunopharmacol. Immunotoxicol., 2008, 30, 867-882.
154. Sugiyama, T.; Kawaguchi, K.; Dobashi, H.; Miyake, R.; Kaneko, M.; Kumazawa, Y. Quercetin but not luteolin suppresses the induction of lethal shock upon infection of mice with Salmonella typhimurium. FEMS Immunol. Med. Microbiol., 2008, 53, 306-313.
155. Nam, N.H. Naturally occurring NF-kappaB inhibitors. Mini Rev. Med. Chem., 2006, 6, 945-951.
156. Ying, B.; Yang, T.; Song, X.; Hu, X.; Fan, H.; Lu, X.; Chen, L.; Cheng, D.; Wang, T.; Liu, D.; Xu, D.; Wei, Y.; Wen, F. Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Mol. Biol. Rep., 2009, 36, 1825-1832.
157. Lotito, S.B.; Frei, B. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. J. Biol. Chem., 2006, 281, 37102-37110.
158. Jacobson, K.A.; Moro, S.; Manthey, J.A.; West, P.L.; Ji, X.D. Interactions of flavones and other phytochemicals with adenosine receptors. Flavonoids Cell Funct., 2002, 505, 163-171.
159. Schwartz, A.; Sutton, S.L.; Middleton, E. Jr. Quercetin inhibition of the induction and function of cytotoxic T lymphocytes. Immunopharmacology, 1982, 4, 125-138.
160. Liu, J.; Li, X.; Yue, Y.; Li, J.; He, T.; He, Y. The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils. Cell Mol. Immunol., 2005, 2, 455-460.
161. Schneider, C.; Berton, G.; Spisani, S.; Traniello, S.; Romeo, D. Quercetin, a regulator of polymorphonuclear leukocyte (PMNL) functions. Adv. Exp. Med. Biol., 1979, 121, 371-379.
162. Berton, G.; Schneider, C.; Romeo, D. Inhibition by quercetin of activation of polymorphonuclear leucocyte functions. Stimulusspecific effects. Biochim. Biophys. Acta., 1980, 595, 47-55.
163. Park, H.J.; Lee, C.M.; Jung, I.D.; Lee, J.S.; Jeong, Y.I.; Chang, J.H.; Chun, S.H.; Kim, M.J.; Choi, I.W.; Ahn, S.C.; Shin, Y.K.; Yeom, S.R.; Park, Y.M. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int. Immunopharmacol., 2009, 9, 261-267.
164. Fanning, M.J.; Macander, P.; Drzewiecki, G.; Middleton, E. Jr. Quercetin inhibits anaphylactic contraction of guinea pig ileum smooth muscle 4983. Int. Arch. Allergy Appl. Immunol., 1983, 71, 371-373.
165. Ando, C.; Takahashi, N.; Hirai, S.; Nishimura, K.; Lin, S.; Uemura, T.; Goto, T.; Yu, R.; Nakagami, J.; Murakami, S.; Kawada, T. Luteolin, a food-derived flavonoid, suppresses adipocytedependent activation of macrophages by inhibiting JNK activation. FEBS Lett., 2009, 583, 3649-3654.
166. Gutierrez-Venegas, G.; Kawasaki-Cardenas, P.; rroyo-Cruz, S.R.; Maldonado-Frias, S. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur. J. Pharmacol., 2006, 541, 95-105.
167. Mi, L.K.; Lee, K.W.; Jung, S.K.; Lee, E.J.; Heo, Y.S.; Bode, A.M.; Lubet, R.A.; Lee, H.J.; Dong, Z. Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity. Biochem. Pharmacol., 2010.
168. Lee, J.K.; Kim, S.Y.; Kim, Y.S.; Lee, W.H.; Hwang, D.H.; Lee, J.Y. Suppression of the TRIF-dependent signaling pathway of Tolllike receptors by luteolin. Biochem. Pharmacol., 2009, 77, 1391-1400.
169. Ferriola, P.C.; Cody, V.; Middleton, E. Jr. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structureactivity relationships. Biochem. Pharmacol., 1989, 38, 1617-1624.
170. Kuppusamy, U.R.; Das, N.P. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem. Pharmacol., 1992, 44, 1307-1315.
171. Nagao, A.; Seki, M.; Kobayashi, H. Inhibition of xanthine oxidase by flavonoids. Biosci. Biotechnol. Biochem., 1999, 63, 1787-1790.
172. Pauff, J.M.; Hille, R. Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin. J. Nat. Prod., 2009, 72, 725-731.
173. Olszanecki, R.; Gebska, A.; Kozlovski, V.I.; Gryglewski, R.J. Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol., 2002, 53, 571-584.
174. Yanoshita, R.; Chang, H.W.; Son, K.H.; Kudo, I.; Samejima, Y. Inhibition of lysoPAF acetyltransferase activity by flavonoids. Inflamm. Res., 1996, 45, 546-549.
175. Kavutcu, M.; Melzig, M.F. In vitro effects of selected flavonoids on the 5'-nucleotidase activity. Pharmazie, 1999, 54, 457-459.
176. Bormann, H.; Melzig, M.F. Inhibition of metallopeptidases by flavonoids and related compounds. Pharmazie, 2000, 55, 129-132.
177. Hwang, J.T.; Kwon, D.Y.; Yoon, S.H. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N. Biotechnol., 2009, 26, 17-22.
178. Katalinic, M.; Rusak, G.; Domacinovic, B.J.; Sinko, G.; Jelic, D.; Antolovic, R.; Kovarik, Z. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur. J. Med. Chem., 2010, 45(1), 186-192.
179. Agullo, G.; Gamet-Payrastre, L.; Manenti, S.; Viala, C.; Remesy, C.; Chap, H.; Payrastre, B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol., 1997, 53, 1649-1657.
180. Benedek, B.; Kopp, B.; Melzig, M.F. Achillea millefolium L. s.l. -- is the anti-inflammatory activity mediated by protease inhibition? J. Ethnopharmacol., 2007, 113, 312-317.
181. Fernandez-Salguero, P.M.; Hilbert, D.M.; Rudikoff, S.; Ward, J.M.; Gonzalez, F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol., 1996, 140, 173-179.
182. Carlson, D.B.; Perdew, G.H. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J. Biochem. Mol. Toxicol., 2002, 16, 317-325.
183. Elferink, C.J.; Gasiewicz, T.A.; Whitlock, J.P., Jr. Protein-DNA interactions at a dioxin-responsive enhancer. Evidence that the transformed Ah receptor is heteromeric. J. Biol. Chem., 1990, 265, 20708-20712.
184. Schrenk, D. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem. Pharmacol., 1998, 55, 1155-1162.
185. Kimura, Y.; Ito, H.; Ohnishi, R.; Hatano, T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem. Toxicol., 2010, 48, 429-435.
186. Chan, H.Y.; Chen, Z.Y.; Tsang, D.S.; Leung, L.K. Baicalein inhibits DMBA-DNA adduct formation by modulating CYP1A1 and CYP1B1 activities. Biomed. Pharmacother., 2002, 56, 269-275.
187. Zhang, S.; Qin, C.; Safe, S.H. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ. Health Perspect., 2003, 111, 1877-1882.
188. Amakura, Y.; Tsutsumi, T.; Sasaki, K.; Nakamura, M.; Yoshida, T.; Maitani, T. Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. Phytochemistry, 2008, 69, 3117-3130.
189. Sergent, T.; Dupont, I.; Van der, H.E.; Scippo, M.L.; Pussemier, L.; Larondelle, Y.; Schneider, Y.J. CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells. Toxicol. Lett., 2009, 191, 216-222.
190. Choi, Y.J.; Arzuaga, X.; Kluemper, C.T.; Caraballo, A.; Toborek, M.; Hennig, B. Quercetin blocks caveolae-dependent proinflammatory responses induced by co-planar PCBs. Environ. Int., 2009, [Epub ahead of print].
191. Chen, Y.; Xiao, P.; Ou-Yang, D.S.; Fan, L.; Guo, D.; Wang, Y.N.; Han, Y.; Tu, J.H.; Zhou, G.; Huang, Y.F.; Zhou, H.H. The simultaneous effects of flavonoid quercetin on the activities of CYP1A2, CYP2A6, NAT2 and XO in healthy volunteers. Clin. Exp. Pharmacol. Physiol., 2009, 36(8), 823-833.
192. Chen, Y.; Xiao, P.; Ou-Yang, D.S.; Fan, L.; Guo, D.; Wang, Y.N.; Han, Y.; Tu, J.H.; Zhou, G.; Huang, Y.F.; Zhou, H.H. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers. Clin. Exp. Pharmacol. Physiol., 2009, 36, 828-833.
193. Hamada, M.; Satsu, H.; Ashida, H.; Sugita-Konishi, Y.; Shimizu, M. Metabolites of Galangin by 2,3,7,8-Tetrachlorodibenzo-pdioxin- Inducible Cytochrome P450 1A1 in Human Intestinal Epithelial Caco-2 Cells and Their Antagonistic Activity toward Aryl Hydrocarbon Receptor. J. Agric. Food Chem., 2010, (in press).
194. Ashida, H. Suppressive effects of flavonoids on dioxin toxicity. Biofactors, 2000, 12, 201-206.
195. Stopper, H.; Schmitt, E.; Kobras, K. Genotoxicity of phytoestrogens. Mutat.Res., 2005, 574, 139-155.
196. Crinnion, W.J. Organic foods contain higher levels of certain nutrients, lower levels of pesticides, and may provide health benefits for the consumer. Altern. Med. Rev., 2010, 15, 4-12.
197. Dertinger, S.D.; Nazarenko, D.A.; Silverstone, A.E.; Gasiewicz, T.A. Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensateinduced cytogenetic damage in vivo. Carcinogenesis, 2001, 22, 171-177.
198. Bothe, H.; Gotz, C.; Stobbe-Maicherski, N.; Fritsche, E.; Abel, J.; Haarmann-Stemmann, T. Luteolin enhances the bioavailability of benzo(a)pyrene in human colon carcinoma cells. Arch. Biochem. Biophys., 2010, 498, 111-118.
199. Reyes-Hernandez, O.D.; Mejia-Garcia, A.; Sanchez-Ocampo, E.M.; Castro-Munozledo, F.; Hernandez-Munoz, R.; Elizondo, G. Aromatic hydrocarbons upregulate glyceraldehyde-3-phosphate dehydrogenase and induce changes in actin cytoskeleton. Role of the aryl hydrocarbon receptor (AhR). Toxicology, 2009, 266, 30-37.
200. Mukai, R.; Shirai, Y.; Saito, N.; Fukuda, I.; Nishiumi, S.; Yoshida, K.I.; Ashida, H. Suppression mechanisms of flavonoids on aryl hydrocarbon receptor-mediated signal transduction. Arch. Biochem. Biophys., 2010, (in press).
201. Fukuda, I.; Mukai, R.; Kawase, M.; Yoshida, K.; Ashida, H. Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids. Biochem. Biophys. Res. Commun., 2007, 359, 822-827.
202. Lu, Y.F.; Santostefano, M.; Cunningham, B.D.; Threadgill, M.D.; Safe, S. Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. Biochem. Pharmacol., 1996, 51, 1077-1087.
203. Ciolino, H.P.; Daschner, P.J.; Yeh, G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J., 1999, 340 (Pt. 3), 715-722.
204. Reiners, J.J. Jr.; Clift, R.; Mathieu, P. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor. Carcinogenesis, 1999, 20, 1561-1566.
205. Apetoh, L.; Quintana, F.J.; Pot, C.; Joller, N.; Xiao, S.; Kumar, D.; Burns, E.J.; Sherr, D.H.; Weiner, H.L.; Kuchroo, V.K. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol., 2010, (in press).
206. Veldhoen, M.; Hirota, K.; Westendorf, A.M.; Buer, J.; Dumoutier, L.; Renauld, J.C.; Stockinger, B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature, 2008, 453, 106-109.
207. Quintana, F.J.; Basso, A.S.; Iglesias, A.H.; Korn, T.; Farez, M.F.; Bettelli, E.; Caccamo, M.; Oukka, M.; Weiner, H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature, 2008, 453, 65-71.
208. Esser, C.; Rannug, A.; Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends. Immunol., 2009, 30, 447-454.
209. Stevens, E.A.; Mezrich, J.D.; Bradfield, C.A. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology, 2009, 127, 299-311.
210. Berryman, L. and Czuprynski, C.J. Flavonoid treatment of murine macrophages does not alter ingestion or intracellular survival of Listeria monocytogenes. Immunopharmacol. Immunotoxicol., 2008, 30, 217-226.
211. Ashida, H.; Nishiumi, S.; Fukuda, I. An update on the dietary ligands of the AhR. Expert Opin. Drug Metab. Toxicol., 2008, 4, 1429-1447.
212. Bankoti, J.; Burnett, A.; Navarro, S.; Miller, A.K.; Rase, B.; Shepherd, D.M. Effects of TCDD on the fate of naive dendritic cells. Toxicol. Sci., 2010, 115, 422-434.
213. Bankoti, J.; Rase, B.; Simones, T.; Shepherd, D.M. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol. Appl. Pharmacol., 2010, 246, 18-28.
214. Head, J.L.; Lawrence, B.P. The aryl hydrocarbon receptor is a modulator of anti-viral immunity. Biochem. Pharmacol., 2009, 77, 642-653.
215. Lawrence, B.P. Environmental toxins as modulators of antiviral immune responses. Viral Immunol., 2007, 20, 231-242.
216. Cua, D.J.; Tato, C.M. Innate IL-17-producing cells: the sentinels of the immune system. Na.t Rev. Immunol., 2010, 10, 479-489.
217. Kang, H.K.; Ecklund, D.; Liu, M.; Datta, S.K. Apigenin, a nonmutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis. Res. Ther., 2009, 11, R59.
218. Kawai, M.; Hirano, T.; Higa, S.; Arimitsu, J.; Maruta, M.; Kuwahara, Y.; Ohkawara, T.; Hagihara, K.; Yamadori, T.; Shima, Y.; Ogata, A.; Kawase, I.; Tanaka, T. Flavonoids and related compounds as anti-allergic substances. Allergol. Int., 2007, 56, 113-123.
219. Saraf, A.S.; Oganesyan, E.T. Flavonoids as potential antiallergic agents. Khimiko-Farmatsevticheskii Zhurnal, 1991, 25, 4-8.
220. Simons, F.E. 9. Anaphylaxis. J. Allergy Clin. Immunol., 2008, 121, S402-S407.
221. Mukai, K.; Obata, K.; Tsujimura, Y.; Karasuyama, H. New insights into the roles for basophils in acute and chronic allergy. Allergol. Int., 2009, 58, 11-19.
222. Karasuyama, H.; Mukai, K.; Tsujimura, Y.; Obata, K. Newly discovered roles for basophils: a neglected minority gains new respect. Nat. Rev. Immunol., 2009, 9, 9-13.
223. Gibbs, B.F.; Streatfield, C.; Falcone, F.H. Basophils as critical orchestrators of Th2-type immune responses. Expert. Rev. Clin. Immunol., 2009, 5, 725-734.
224. Sokol, C.L.; Medzhitov, R. Role of basophils in the initiation of Th2 responses. Curr. Opin. Immunol., 2010, 22, 73-77.
225. Kawakami, T. Basophils now enhance memory. Nat. Immunol., 2008, 9, 720-721.
226. Denzel A; Maus UA; Gomez MR; Moll C; Niedermeier M; Winter C; Maus R; Hollingshead S; Briles D.E.; Kunz-Schughart Leoni A; Talke Y; Mack M. Basophils enhance immunological memory responses. Nature, 2008, 9, 733-742.
227. Maddur, M.S.; Kaveri, S.V.; Bayry, J. Basophils as antigen presenting cells. Trends. Immunol., 2010, 31, 45-48.
228. Gauvreau, G.M.; Plitt, J.R.; Baatjes, A.; MacGlashan, D.W. Expression of functional cysteinyl leukotriene receptors by human basophils. J. Allergy Clin. Immunol., 2005, 116, 80-87.
229. Min, B.; Paul, W.E. Basophils and type 2 immunity. Curr. Opin. Hematol., 2008, 15, 59-63.
230. Stone, K.D.; Prussin, C.; Metcalfe, D.D. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol., 2010, 125, S73-S80.
231. Yamaguchi, M.; Koketsu, R.; Suzukawa, M.; Kawakami, A.; Iikura, M. Human basophils and cytokines/chemokines. Allergol. Int., 2009, 58, 1-10.
232. Schroeder, J.T.; Chichester, K.L.; Bieneman, A.P. Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J. Immunol., 2009, 182, 2432-2438.
233. Hennersdorf, F.; Florian, S.; Jakob, A.; Baumgartner, K.; Sonneck, K.; Nordheim, A.; Biedermann, T.; Valent, P.; Buhring, H.J. Identification of CD13, CD107a, and CD164 as novel basophilactivation markers and dissection of two response patterns in time kinetics of ige-dependent upregulation. Cell Res., 2005, 15, 325-335.
234. de Weck, A.L.; Sanz, M.L.; Gamboa, P.M.; Aberer, W.; Bienvenu, J.; Blanca, M.; Demoly, P.; Ebo, D.G.; Mayorga, L.; Monneret, G.; Sainte-Laudy, J. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int. Arch. Allergy Immunol., 2008, 146, 177-189.
235. Chirumbolo, S.; Vella, A.; Ortolani, R.; De Gironcoli M.; Solero, P.; Tridente, G.; Bellavite, P. Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. Clin. Mol. Allergy, 2008, 6, 12.
236. Schroeder, J.T. Basophils beyond effector cells of allergic inflammation. Adv. Immunol., 2009, 101, 123-161.
237. Ehrlich, P. Beiträge zur Kenntnis der granulierten Bindegewebszellen und der eosinophilen Leukocythen. Arch. Anat. Physiol., 1879, 166-169.
238. Arinobu, Y.; Iwasaki, H.; Akashi, K. Origin of basophils and mast cells. Allergol. Int., 2009, 58, 21-28.
239. Marone, G.; Triggiani, M.; de, P.A. Mast cells and basophils: friends as well as foes in bronchial asthma? Trends. Immunol., 2005, 26, 25-31.
240. Crivellato, E.; Travan, L.; Ribatti, D. Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation. Int. Arch. Allergy Immunol., 2010, 151, 89-97.
241. Igura, K.; Ohta, T.; Kuroda, Y.; Kaji, K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett., 2001, 171, 11-16.
242. Kong L; Wu K; Lin H. Inhibitory effects of quercetin on angiogenesis of experimental mammary carcinoma. Chin. J. Clin. Oncol., 2005, 2, 631-636.
243. Donnini, S.; Finetti, F.; Lusini, L.; Morbidelli, L.; Cheynier, V.; Barron, D.; Williamson, G.; Waltenberger, J.; Ziche, M. Divergent effects of quercetin conjugates on angiogenesis. Br. J. Nutr., 2006, 95, 1016-1023.
244. Jung, M.K.; Hur, D.Y.; Song, S.B.; Park, Y.; Kim, T.S.; Bang, S.I.; Kim, S.; Song, H.K.; Park, H.; Cho, D.H. Tannic acid and quercetin display a therapeutic effect in atopic dermatitis via suppression of angiogenesis and TARC expression in Nc/Nga mice. J. Invest. Dermatol., 2010, 130, 1459-1463.
245. Miller, A.L. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Altern. Med. Rev., 2001, 6, 20-47.
246. Rogerio, A.P.; Dora, C.L.; Andrade, E.L.; Chaves, J.S.; Silva, L.F.; Lemos-Senna, E.; Calixto, J.B. Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. Pharmacol. Res., 2010, 61, 288-297.
247. Foreman, J.C. Mast cells and the actions of flavonoids. J. Allergy Clin. Immunol., 1984, 73, 769-774.
248. Middleton, E. Jr.; Drzewiecki, G.; Krishnarao, D. Quercetin: an inhibitor of antigen-induced human basophil histamine release. J. Immunol., 1981, 127, 546-550.
249. Middleton, E. Jr.; Krishnarao, D.G.; Atkins, D.; Drzewiecki, G. The flavonoids: a brief review and study of effects on antigeninduced histamine release from human basophils. Trans. Am. Clin. Climatol. Assoc., 1981, 92, 234-252.
250. Middleton, E. Jr.; Drzewiecki, G. Effects of flavonoids and transitional metal cations on antigen-induced histamine release from human basophils. Biochem. Pharmacol., 1982, 31, 1449-1453.
251. Middleton, E. Jr.; Drzewiecki, G. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem. Pharmacol., 1984, 33, 3333-3338.
252. Middleton, E. Jr. Effect of flavonoids on basophil histamine release and other secretory systems. Prog. Clin. Biol. Res., 1986, 213, 493-506.
253. Ezeamuzie, I.C.; Assem, E.S. Modulation of the effect of histamine-releasing lymphokine on human basophils. Agents Actions, 1984, 14, 501-505.
254. Gong, J.; Chen, S.S. Polyphenolic antioxidants inhibit peptide presentation by antigen-presenting cells. Int. Immunopharmacol., 2003, 3, 1841-1852.
255. Bennett, J.P.; Gomperts, B.D.; Wollenweber, E. Inhibitory effects of natural flavonoids on secretion from mast cells and neutrophils. Arzneimittelforschung, 1981, 31, 433-437.
256. Pruzansky, J.J.; Zeiss, C.R.; Patterson, R. A linear correlation between histamine release and degranulation of human basophils by specific antigen or the ionophore A23187. Immunology, 1980, 40, 411-416.
257. Dvorak, A.M.; Newball, H.H.; Dvorak, H.F.; Lichtenstein, L.M. Antigen-induced IgE-mediated degranulation of human basophils. Lab. Invest., 1980, 43, 126-139.
258. de Weck, A.L.; Sanz, M.L.; Gamboa, P.M.; Aberer, W.; Bienvenu, J.; Bianca, M.; Demoly, P.; Ebo, D.G.; Mayorga, L.; Monneret, G.; Sainte-Laudy, J. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls: II Technical issues. J. Invest. Allergol. Clin. Immunol., 2008, 18, 143-155.
259. Ogasawara, H.; Fujitani, T.; Drzewiecki, G.; Middleton E Jr The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. J. Allergy Clin. Immunol., 1986, 78, 321-328.
260. Ebo, D.G.; Bridts, C.H.; Hagendorens, M.M.; Aerts, N.E.; De Clerck, L.S.; Stevens, W.J. Basophil activation test by flow cytometry: present and future applications in allergology. Cytom. B. Clin. Cytom., 2008, 74, 201-210.
261. Chirumbolo, S.; Conforti, A.; Ortolani, R.; Vella, A.; Marzotto, M.; Bellavite, P. Stimulus-specific regulation of CD63 and CD203c membrane expression in human basophils by the flavonoid quercetin. Int. Immunopharmacol., 2010, 10, 183-192.
262. Guerin-Marchand, C.; Senechal, H.; Pelletier, C.; Fuher, H.; Olivier, R.; David, B.; Berthon, B. Blank U H2O2 impairs inflammatory mediator release from immunologically stimulated RBL-2H3 cells through a redox-sensitive, calcium-dependent mechanism. Inflamm. Res., 2001, 50, 341-349.
263. Fewtrell, C.M.; Gomperts, B.D. Quercetin: a novel inhibitor of Ca2+ influx and exocytosis in rat peritoneal mast cells. Biochim. Biophys. Acta., 1977, 469, 52-60.
264. Lee, E.; Choi, E.J.; Cheong, H.; Kim, Y.R.; Ryu, S.Y.; Kim, K.M. Anti-allergic actions of the leaves of Castanea crenata and isolation of an active component responsible for the inhibition of mast cell degranulation. Arch. Pharm. Res., 1999, 22, 320-323.
265. Haggag, E.G.; bou-Moustafa, M.A.; Boucher, W.; Theoharides, T.C. The effect of a herbal water-extract on histamine release from mast cells and on allergic asthma. J. Herb. Pharmacother., 2003, 3, 41-54.
266. Pearce, F.L.; Befus, A.D.; Bienenstock, J. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J. Allergy Clin. Immunol., 1984, 73, 819-823.
267. Passante, E.; Ehrhardt, C.; Sheridan, H.; Frankish, N. RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflamm. Res., 2009, 58, 611-618.
268. Martin, M.W.; O'Sullivan, A.J.; Gomperts, B.D. Inhibition by cromoglycate and some flavonoids of nucleoside diphosphate kinase and of exocytosis from permeabilized mast cells. Br. J. Pharmacol., 1995, 115, 1080-1086.
269. Matsushima, M.; Takagi, K.; Ogawa, M.; Hirose, E.; Ota, Y.; Abe, F.; Baba, K.; Hasegawa, T.; Hasegawa, Y.; Kawabe, T. Heme oxygenase-1 mediates the anti-allergic actions of quercetin in rodent mast cells. Inflamm. Res., 2009, 58, 705-715.
270. Hayes, N.A.; Foreman, J.C. The activity of compounds extracted from feverfew on histamine release from rat mast cells. J. Pharm. Pharmacol., 1987, 39, 466-470.
271. Kurose, M. Inhibition of anaphylactic histamine release from heterologously sensitized mast cells: differential effects of drugs which interfere with calcium influx. Acta. Med. Okayama., 1981, 35, 307-317.
272. Saeki, K.; Kurose, M. Histamine release from rat mast cells sensitized with mouse antiserum. Agents. Actions., 1981, 11, 98-100.
273. Walker, E.H.; Pacold, M.E.; Perisic, O.; Stephens, L.; Hawkins, P.T.; Wymann, M.P.; Williams, R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell., 2000, 6, 909-919.
274. Ennis, M.; Truneh, A.; White, J.R.; Pearce, F.L. Inhibition of histamine secretion from mast cells. Nature, 1981, 289, 186-187.
275. White, J.R.; Pearce, F.L. Effect of anti-allergic compounds on anaphylactic histamine secretion from rat peritoneal mast cells in the presence and absence of exogenous calcium. Immunology, 1982, 46, 361-367.
276. White, J.R.; Pearce, F.L. Effect of anti-allergic and cyclic AMPactive drugs on histamine secretion from rat mast cells treated with the novel calcium ionophore chlortetracycline. Int. Arch. Allergy Appl. Immunol., 1983, 71, 352-356.
277. Parker, W.L.; Martz, E. Calcium ionophore A23187 as a secretagogue for rat mast cells: does it bypass inhibition by calcium flux blockers? Agents Actions, 1982, 12, 276-284.
278. Walker, E.H.; Pacold, M.E.; Perisic, O.; Stephens, L.; Hawkins, P.T.; Wymann, M.P.; Williams, R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, ly294002, quercetin, myricetin, and staurosporine. Mol. Cell, 2000, 6, 909-919.
279. Rommel, C.; Camps, M.; Ji, H. PI3Kd and PI3Kg: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat. Rev. Immunol., 2007, 7, 191-201.
280. Miura, K.; Macglashan, D.W. Jr. Expression of protein kinase C isozymes in human basophils: regulation by physiological and nonphysiological stimuli. Blood, 1998, 92, 1206-1218.
281. Warner, J.A.; Macglashan, D.W. Jr. Protein kinase C (PKC) changes in human basophils. IgE-mediated activation is accompanied by an increase in total PKC activity. J. Immunol., 1989, 142, 1669-1677.
282. Viard, P.; Butcher, A.J.; Halet, G.; Davies, A.; Nurnberg, B.; Heblich, F.; Doplhin, A.C. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat. Neurosci., 2004, 7, 939-946.
283. Navarro-Nunez, L.; Lozano, M.L.; Martinez, C.; Vicente, V.; Rivera, J. Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases. Fitoterapia, 2010, 81, 75-80.
284. Arcaro, A.; Wymann, M.P. Wortmannin is a potent phosphoinositide-3 kinase inhibitor: the role of phosphatidylinositol-3,4,5 triphosphate in neutrophil responses. Biochem. J., 1993, 296, 297-301.
285. Brock, C.; Schaefer, M.; Reusch, H.P.; Czupalla, C.; Michalke, M.; Spicher, K.; Schultz, G.; Nurnberg, B. Roles of Gbetagamma in membrane recruitment and activation of p110gamma/p101 phosphoinositide 3-kinase gamma. J. Cell. Biol., 2003, 160, 89-99.
286. Mocsai, A.; Jakus, Z.; Vantus, T.; Berton, G.; Lowell, C.A.; Ligeti, E. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J. Immunol., 2000, 164, 4321-4331.
287. Woo, C.S.; Chan, W.; Sampson, H.A.; Shreffler, W.G. Cell-by-cell characterization of signaling and activation marker upregulation during basophil stimulation and non specific desensitization. J. Allergy Clin. Immunol., 2009, 123, S199-post 764.
288. Bergstrand, H.; Lundquist, B. Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner. Allergy, 2007, 47, 353-361.
289. Nishino, H.; Naitoh, E.; Iwashima, A.; Umezawa, K. Quercetin interacts with calmodulin, a calcium regulatory protein. Experientia, 1984, 40, 184-185.
290. Dvorak, A.M. Ultrastructural studies of human basophils and mast cells. J. Histochem. Cytochem., 2005, 53, 1043-1070.
291. Johri, R.K.; Zutshi, U.; Kameshwaran, L.; Atal, C.K. Effect of quercetin and Albizzia saponins on rat mast cell. Indian J. Physiol. Pharmacol., 1985, 29, 43-46.
292. Wang, Y.Z.; Palmer, J.M.; Cooke, H.J. Neuroimmune regulation of colonic secretion in guinea pigs. Am. J. Physiol., 1991, 260, G307-G314.
293. Castellani, M.L.; Kempuraj, D.; Frydas, S.; Theoharides, T.C.; Simeonidou, I.; Conti, P.; Vecchiet, J. Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation., 2006, 13, 179-186.
294. Kempuraj, D.; Castellani, M.L.; Petrarca, C.; Frydas, S.; Conti, P.; Theoharides, T.C.; Vecchiet, J. Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Clin. Exp. Med., 2006, 6, 150-156.
295. Alexandrakis, M.; Singh, L.; Boucher, W.; Letourneau, R.; Theofilopoulos, P.; Theoharides, T.C. Differential effect of flavonoids on inhibition of secretion and accumulation of secretory granules in rat basophilic leukemia cells. Int. J. Immunopharmacol., 1999, 21, 379-390.
296. Trnovsky, J.; Letourneau, R.; Haggag, E.; Boucher, W.; Theoharides, T.C. Quercetin-induced expression of rat mast cell protease II and accumulation of secretory granules in rat basophilic leukemia cells. Biochem. Pharmacol., 1993, 46, 2315-2326.
297. Trnovsky, J.; Letourneau, R.; Theoharides, T.C. Quercetin induces differentiation maturation of rat basophilic leukemia (Rbl) cells. FASEB. J., 1991, 5, A1006-A1006.
298. Segawa, S.; Yasui, K.; Takata, Y.; Kurihara, T.; Kaneda, H.; Watari, J. Flavonoid glycosides extracted from hop (Humulus lupulus L.) as inhibitors of chemical mediator release from human basophilic KU812 cells. Biosci. Biotechnol. Biochem., 2006, 70, 2990-2997.
299. Xu, F.; Matsuda, H.; Hata, H.; Sugawara, K.; Nakamura, S.; Yoshikawa, M. Structures of new flavonoids and benzofuran-type stilbene and degranulation inhibitors of rat basophilic leukemia cells from the Brazilian herbal medicine Cissus sicyoides. Chem. Pharm. Bull. (Tokyo), 2009, 57, 1089-1095.
300. Senyshyn, J.; Baumgartner, R.A.; Beaven, M.A. Quercetin sensitizes RBL-2H3 cells to polybasic mast cell secretagogues through increased expression of Gi GTP-binding proteins linked to a phospholipase C signaling pathway. J. Immunol., 1998, 160, 5136-5144.
301. Zussman, A.; Sagi-Eisenberg, R. Stimulation of Ca(2+)-dependent exocytosis and release of arachidonic acid in cultured mast cells (RBL-2H3) by quercetin. Int. J. Immunopharmacol., 2000, 22, 747-754.
302. Chahdi, A.; Fraundorfer, P.F.; Beaven, M.A. Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTPbinding proteins. J. Pharmacol. Exp. Ther., 2000, 292, 122-130.
303. Chakravarty, N. The role of plasma membrane Ca++-Mg++ activated adenosine triphosphatase of rat mast cells on histamine release. Acta. Pharmacol. Toxicol. (Copenh), 1980, 47, 223-235.
304. Chandler, D.; Woldu, A.; Rahmadi, A.; Shanmugam, K.; Steiner, N.; Wright, E.; avente-Garcia, O.; Schulz, O.; Castillo, J.; Munch, G. Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts. Mol. Nutr. Food Res., 2010, 54(Suppl 2), S141-S150.
305. Harrison, A.P.; Cooper, R.G. Quercetin: health benefits with relevance to TNF-alpha linked inflammatory diseases. J. Preclin. Clin. Res., 2008, 2(2), 135-139.